GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » Operating Income

CryoPort (CryoPort) Operating Income : $-76.8 Mil (TTM As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is CryoPort Operating Income?

CryoPort's Operating Income for the three months ended in Mar. 2024 was $-21.3 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was $-76.8 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. CryoPort's Operating Income for the three months ended in Mar. 2024 was $-21.3 Mil. CryoPort's Revenue for the three months ended in Mar. 2024 was $54.6 Mil. Therefore, CryoPort's Operating Margin % for the quarter that ended in Mar. 2024 was -38.98%.

Good Sign:

CryoPort Inc operating margin is expanding. Margin expansion is usually a good sign.

CryoPort's 5-Year average Growth Rate for Operating Margin % was 20.10% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. CryoPort's annualized ROC % for the quarter that ended in Mar. 2024 was -18.47%. CryoPort's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -45.18%.


CryoPort Operating Income Historical Data

The historical data trend for CryoPort's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CryoPort Operating Income Chart

CryoPort Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.68 -30.01 -17.83 -31.90 -65.59

CryoPort Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.05 -18.33 -16.91 -20.30 -21.28

CryoPort Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-76.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CryoPort  (NAS:CYRX) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

CryoPort's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-85.124 * ( 1 - -1.15% )/( (465.355 + 466.929)/ 2 )
=-86.102926/466.142
=-18.47 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=957.744 - 35.634 - ( 456.755 - max(0, 45.61 - 535.112+456.755))
=465.355

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=942.849 - 27.376 - ( 448.544 - max(0, 48.982 - 525.704+448.544))
=466.929

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

CryoPort's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-69.368/( ( (117.51 + max(38.553, 0)) + (117.037 + max(33.945, 0)) )/ 2 )
=-69.368/( ( 156.063 + 150.982 )/ 2 )
=-69.368/153.5225
=-45.18 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(42.074 + 26.206 + 10.077) - (35.634 + 1.308 + 2.862)
=38.553

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(41.253 + 25.02 + 10.887) - (27.376 + 1.777 + 14.062)
=33.945

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

CryoPort's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-21.281/54.592
=-38.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


CryoPort Operating Income Related Terms

Thank you for viewing the detailed overview of CryoPort's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


CryoPort (CryoPort) Business Description

Traded in Other Exchanges
Address
112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Executives
Robert J Hariri director 341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Jerrell Shelton director, officer: President, CEO C/O NETRATINGS INC, 120 WEST 45TH STREET 35TH FLOOR, NEW YORK NY 10036
Richard J Berman director 305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Robert Stefanovich officer: Chief Financial Officer
Mark W Sawicki officer: Chief Scientific Officer 3303 LAKEPOINTE DRIVE, BELMONT NC 28012
Blackstone Holdings Ii L.p. 10 percent owner C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Tactical Opportunities Fund - Fd L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Daniel M Hancock director 7729 S. BELMONT, INDIANAPOLIS IN 46217
Edward J Zecchini director 20382 BARENTS SEA CIRCLE, LAKE FOREST CA 92630
Linda Baddour director PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Ramkumar Mandalam director 4344 PICKEREL DRIVE, UNION CITY CA 94587
Ram M. Jagannath director C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Stephen A Schwarzman 10 percent owner C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Tactical Opportunities Associates Iii - Nq L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Freeze Parent L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154